Page last updated: 2024-08-23

nitrosobis(2-oxopropyl)amine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

nitrosobis(2-oxopropyl)amine has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaneko, T; Tahara, S; Takabayashi, F1

Other Studies

1 other study(ies) available for nitrosobis(2-oxopropyl)amine and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Protective effect of fluvastatin, an HMG-CoA reductase inhibitor, on the formation of 8-oxo-2'-deoxyguanosine in the nuclear DNA of hamster pancreas after a single administration of N-nitrosobis(2-oxopropyl)amine.
    Biological & pharmaceutical bulletin, 2003, Volume: 26, Issue:9

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Cell Nucleus; Cricetinae; Deoxyguanosine; DNA; DNA Damage; Fatty Acids, Monounsaturated; Female; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Injections, Subcutaneous; Lipid Peroxidation; Mesocricetus; Nitrosamines; Oxidation-Reduction; Pancreas; Thiobarbituric Acid Reactive Substances

2003